Skip to main content

Table 1 Baseline characteristics

From: The impact of spinal anaesthesia on perioperative opioid consumption, postoperative pain and oncological outcome in radical retropubic prostatectomy—a retrospective before-and-after effectiveness study

 

SPA (n = 318)

GA (n = 318)

P-value

Age [years]

64 ± 7.0

64 ± 7.3

0.093

Height [cm]

179 ± 6.0

179 ± 6.7

0.408

Weight [kg]

86 ± 10.6

87 ± 11.7

0.130

BMI [kg·m−2]

26.7 ± 3.0

27.0 ± 3.1

0.379

Hb before surgery [g·dl−1]

14.7 ± 1.0

14.7 ± 1.0

0.921

ASA physical status class

  

 < 0.001

 II

268 (84.3)

221 (69.5)

 

 III

50 (15.7)

97 (30.5)

 

Preoperative medication

 Betablocker

40 (12.6)

67 (21.1)

0.006

 Diuretics

21 (6.6)

41 (12.9)

0.011

 Antiarrhythmics

2 (0.6)

7 (2.2)

0.177

 Metabolic

81 (25.5)

107 (33.6)

0.03

 ASS/anticoagulants

16 (5.0)

72 (22.6)

 < 0.001

 Analgesics

6 (1.9)

8 (2.5)

0.788

 Antihypertensives

114 (35.8)

148 (46.5)

0.008

 Urological

51 (16.0)

46 (14.5)

0.659

 Pulmonary

16 (5.0)

14 (4.4)

0.852

 Neurological

15 (4.7)

14 (4.4)

1.0

 Gastroenterological

35 (11.0)

39 (12.3)

0.711

 Ophthalmological

8 (2.5)

12 (3.8)

0.497

 Others

24 (7.5)

52 (16.4)

0.001

 None

104 (32.7)

62 (19.5)

 < 0.001

  1. Values are mean ± SD for continuous data or n (%) for categorical data. P-values are displayed as results from nonparametric analysis (by Mann–Whitney U test) for metric variables and from Fisher’s exact test for categorical data (ASA class and preoperative medication)
  2. SPA group Spinal anaesthesia preceding general anaesthesia, GA group General anaesthesia alone, BMI Body mass index, Hb Haemoglobin level, ASA American Society of Anesthesiologists